UAMY - Beautiful Setup with Key Changes in Management

New CEO is Mr. Evans Evans has served for 24 years as a Director of Novavax Inc., a NASDAQ listed (“NVAX”) clinical-stage vaccine biotechnology company (Covid-19 Vaccine) with a market capitalization in excess of $15 Billion, and previously served as Chairman, CEO and Lead Director.

Gary Evans has been buying the stock and now owns 1millin share @ price of $0.45

Volume is really low at the moment but Money flow has been consistently +ve
with Golden star indicator on a daily which is a really bullish signal.
Currently showing under consolidation

Little bit of volume can really send it

5million share buyback was announced by the company in latest 10Q